Scientific Program – FETOMATERNAL MEDICINEFriday, November 13 & Saturday, November 14, 2026 |
 |
Friday, November 13
| 08:30-10:00 | FROM PREDICTION TO PREVENTION IN OBSTETRICS | HALL D |
| Chairpersons |
TBA |
|
| 08:30-08:50
08:30 |
Debate: Should we provide aspirin for all? Pro: |
|
| 08:50-09:10
08:50 |
Debate: Metformin for the obese gravida at early pregnancy? Pro: |
|
| 09:10-09:30
09:10 |
Debate: Tubectomy at cesarean section for risk reduction of ovarian cancer? Pro: |
|
| 09:30-09:40 |
Measurement of sFlt-1 and/or PlGF for preeclampsia risk stratification in the second trimester either as a single predictor or combined with other biomarkers for all? |
|
| 09:40-10:00
09:40 |
Debate: Anatomy scan at 31-33 weeks of gestation? Pro: |
|
| 10:00-10:30 | Coffee break, visit the exhibition and e-poster viewing |
| 10:30-12:00 | IUGR – INTRAUTERINE GROWTH RESTRICTION | HALL D |
| Chairpersons | TBA | |
| 10:30-10:50
10:30 |
Debate: Estimated Fetal Weight (EFW) 3rd percentile, normal doppler indices. When to deliver 36? 37? 38? Later? Pro: |
|
| 10:50-11:10
10:50 |
Debate: Can we prevent the recurrence of fetal growth restriction (FGR)? Is there a role for aspirin? Low Molecular Weight Heparin (LMWH)? Pravastatin? Pro: |
|
| 11:10-11:30
|
Testing the placenta in pregnancies with FGR – black box or crystal ball? What to ask the pathologist? How it guides for future treatment? |
|
| 11:30-12:00 |
Nutrition, supplementation and toxic nutrients in pregnancy: How to integrate our knowledge for better pregnancy outcome? |
|
| 12:00-12:05 | Change of session |
| 12:05-12:30 | PLENARY SESSION | HALL A Streamed to all halls |
| Capsule | TBA | |
| Chairpersons | TBA | |
| 12:05-12:30
|
PCOS in OBGYN (overview of PCO in reproductive life, menopause, pregnancy etc) Terhi Piltonen, Finland |
|
| 12:30-12:35 | Change of session |
| 12:35-13:35 | Industry supported session – HALL A Industry supported session – HALL B |
| 13:35-14:30 | Lunch break, visit the exhibition and e-poster viewing |
| 14:30-15:30 | LARGE FOR GESTATIONAL AGE (LGA) – BEING LARGE IS NOT SO SIMPLE | HALL D |
| Chairpersons |
TBA |
|
| 14:30-14:40 |
Can we accurately predict macrosomia? The use of AI |
|
| 14:40-15:00
14:40 |
Debate: What is the optimal timing and mode of delivery in cases of suspected LGA/macrosomia? Should we offer induction of labor (IOL)? Pro: |
|
| 14:50-15:10
14:50 |
Debate: Should we perform late third trimester oral glucose tolerance test (OGTT) in cases of suspected LGA Pro: |
|
| 15:10-15:30 | TBA | |
| 15:30-15:35 | Change of session |
| 15:35-17:00 | CONTROVERSIES AROUND PROM AND PPROM (PRETERM AND TERM PRELABOR RUPTURE OF MEMBRANES) | HALL D |
| Chairpersons | TBA | |
| 15:35-15:50 |
25 years after the ORCALE protocol – is it time to use broader/different antibiotic coverage in PPROM? |
|
| 15:50-16:10
15:50 |
Debate: Should all women with PPROM receive antenatal corticosteroids at presentation? Pro: |
|
| 16:00-16:20
16:00 |
Debate: PPROM with cerclage: To remove or not to remove? If yes when? After completion of corticosteroids Pro: |
|
| 16:20-16:40
16:20 |
Debate: Should tocolysis be used in PPROM to allow steroid administration? Pro: |
|
| 16:40-17:00 | TBA | |
| 17:00-17:15 | Coffee break, visit the exhibition and e-poster viewing |
| 17:15-18:30 | DIABETES AND OBESITY | HALL D |
| Chairpersons |
Yariv Yogev, Israel |
|
| 17:15-17:35 |
How do you know that your patient is well controlled? |
|
| 17:35-17:55
17:35 |
Debate: When to start pharmacological treatment? Should we use oral agents? Which? Pro: |
|
| 17:55-18:15
17:55 |
Debate: GLP-1 medications for GDM Pro: |
|
| 18:15-18:30 |
Gestational weight gain and pregnancy outcomes after GLP-1 receptor agonist discontinuation |
|
Saturday, November 14
| 08:30-10:00 | PRETERM DELIVERY | HALL D |
| Chairpersons | TBA | |
| 08:30-08:50
08:30 |
Debate: Once cerclage always cerclage? Evidence for prior pregnancy Pro: |
|
| 18:50-09:10
08:50 |
Debate: When to deliver in suspected chorioamnionitis during active labor? To perform immediate cesarean section? Pro: |
|
| 09:10-09:25 |
Should prediction models and new biomarkers replace traditional risk factors in preterm birth screening? |
|
| 09:25-09:45
09:25 |
Debate: Should we administer progesterone after arrested preterm labor after 24 weeks of gestation Pro: |
|
| 09:45-10:00 | TBA | |
| 10:00-10:30 | Coffee break, visit the exhibition and e-poster viewing |
| 10:30-12:00 | CONTROVERSIES ISSUES IN LABOR AND DELIVERY | HALL D |
| Chairpersons |
TBA |
|
| 10:30-10:50
11:30 |
Debate: Induction of labor following a previous cesarean section Pro: Yariv Yogev, Israel |
|
| 10:50-11:10
11:40 |
Debate: Delivery in the extremely premature newborn. Cesarean section for all? Pro: |
|
| 11:10-11:25 |
Second stage cesarean delivery: maternal and neonatal problems and long-term outcome |
|
| 11:25-11:45
11:25 |
Debate: Different countries different medicine? In terms of cesarean section rate Low CS rate: |
|
| 11:45-12:00 |
Is labor ultrasound useful in case of preterm delivery? |
|
| 12:00-12:05 | Change of session |
| 12:05-12:30 | PLENARY SESSION | HALL A Streamed to all halls |
| Capsule | TBA | |
| Chairpersons | TBA | |
| 12:05-12:30 | Epigenetics and reprogramming David Monk, UK |
|
| 12:30-13:30 | Lunch break, visit the exhibition and e-poster viewing |
| 13:30-15:00 | CONTROVERSIES IN TWINS | HALL D |
| Chairpersons |
Asma Khalil, UK |
|
| 13:30-13:40 |
Should we use twin-specific growth charts or singleton charts to diagnose growth restriction? |
|
| 13:40-14:00
13:40 |
Debate: Universal cervical length screening in twins? Pro: Liran Hiersch, Israel |
|
| 14:00-14:20
14:00 |
Debate: Should progesterone be used in twins with a short cervix? Pro: Asma Khalil, UK |
|
| 14:20-14:40
14:20 |
Debate: Does cerclage help or harm in twin pregnancies with cervical shortening? Pro: |
|
| 14:40-15:00
14:40 |
Debate: Should we suggest fetal reduction in Bichorionic/Biamniotic (BC/BA) twins Pro: Yariv Yogev, Israel |
|
| 15:00-16:30 | PANEL EXPERTS CASE DISCUSSION – DAILY DILEMMAS IN MODERN OBSTETRIC | HALL D |
| Chairpersons |
Yariv Yogev, Israel |
|
| Discussants |
Asma Khalil, UK |
|
|
||
